{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:07:56Z","timestamp":1787238476585,"version":"build-2736575974"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To investigate the antitumor effects of aucubin (AC) in non-small cell lung cancer (NSCLC) and uncover its plausible mechanism against lung cancer stem-like cells (LCSCs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In vitro experiments included MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, a reagent commonly used for cell viability assay) and colony formation assays to assess anti-proliferative effects on A549 and NCI-H1975 lung cancer cell lines, wound healing and Transwell invasion assays to evaluate inhibition of cell migration and invasion, tumorsphere-formation experiments to detect changes in NSCLC cell stemness, as well as Western blot and quantitative reverse transcription polymerase chain reaction (qRT-PCR) analyses to measure the expression of LCSC markers (CD44, CD133, Oct4, and Nanog). In vivo experiments were conducted to observe the impact of AC on NSCLC metastasis and mouse survival rates. Further mechanistic studies involved transcriptomic gene set enrichment analysis, Western blot, qRT-PCR, molecular docking, and Surface Plasmon Resonance (SPR) methods to investigate how AC directly targets \u03b2-catenin and promotes its ubiquitin-mediated degradation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key findings<\/jats:title>\n                    <jats:p>AC exerted significant anti-proliferative effects on A549 and NCI-H1975 cells, inhibited cancer cell migration and invasion, reduced the stemness of NSCLC cells, and markedly downregulated the expression of LCSC markers in vitro. In vivo, AC treatment significantly reduced NSCLC metastasis and improved mouse survival rates.<\/jats:p>\n                    <jats:p>Mechanistically, AC blocked the WNT (Wingless-related integration site, a family of secreted lipid-modified signaling glycoproteins that play crucial roles in embryonic development, tissue homeostasis, and regeneration) signaling pathway by downregulating \u03b2-catenin and c-Myc expression. It directly targeted \u03b2-catenin, promoting its degradation via the ubiquitin-proteasome pathway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study uncovers a novel anti-LCSC mechanism of AC, offers alternative strategies for NSCLC treatment, and provides innovative lead compounds for the development of drugs targeting lung cancer stem cells.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jpp\/rgaf081","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T11:22:34Z","timestamp":1756120954000},"page":"1777-1786","source":"Crossref","is-referenced-by-count":1,"title":["Aucubin inhibits the activity of lung cancer stem-like cells by targeting degradation of\n                    <b>\u03b2<\/b>\n                    -catenin"],"prefix":"10.1093","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7052-8617","authenticated-orcid":false,"given":"Qian","family":"Li","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, Hebei Medical University Third Hospital. No. 139 Ziqiang Road , Qiaoxi District, Shijiazhuang 050051 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Hebei Medical University Third Hospital. No. 139 Ziqiang Road , Qiaoxi District, Shijiazhuang 050051 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linli","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Hebei Medical University Third Hospital. No. 139 Ziqiang Road , Qiaoxi District, Shijiazhuang 050051 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenying","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Hebei Medical University Third Hospital. No. 139 Ziqiang Road , Qiaoxi District, Shijiazhuang 050051 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqiang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Hebei Medical University Third Hospital. No. 139 Ziqiang Road , Qiaoxi District, Shijiazhuang 050051 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,9,10]]},"reference":[{"key":"2025120200422632100_ref1","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"2025120200422632100_ref2","doi-asserted-by":"crossref","first-page":"102315","DOI":"10.1016\/j.arr.2024.102315","article-title":"Cellular senescence in lung cancer: molecular mechanisms and therapeutic interventions","volume":"97","author":"Jha","year":"2024","journal-title":"Ageing Res Rev"},{"key":"2025120200422632100_ref3","doi-asserted-by":"crossref","first-page":"n2363","DOI":"10.1136\/bmj.n2363","article-title":"Advances in systemic therapy for non-small cell lung cancer","volume":"375","author":"Miller","year":"2021","journal-title":"Bmj"},{"key":"2025120200422632100_ref4","doi-asserted-by":"crossref","first-page":"104080","DOI":"10.1016\/j.critrevonc.2023.104080","article-title":"Neoadjuvant therapy in non-small cell lung cancer","volume":"190","author":"Grant","year":"2023","journal-title":"Crit Rev Oncol Hematol"},{"key":"2025120200422632100_ref5","first-page":"a037713","volume-title":"Radiation Therapy in Non-Small-Cell Lung Cancer","author":"Dohopolski","year":"2021"},{"key":"2025120200422632100_ref6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3892\/mco.2025.2837","article-title":"Treatment of advanced-stage non-small cell lung cancer: current progress and a glimpse into the future (review)","volume":"22","author":"Wang","year":"2025","journal-title":"Mol Clin Oncol"},{"key":"2025120200422632100_ref7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13045-020-00881-7","article-title":"Emerging therapeutic agents for advanced non-small cell lung cancer","volume":"13","author":"Chen","year":"2020","journal-title":"J Hematol Oncol"},{"key":"2025120200422632100_ref8","doi-asserted-by":"crossref","first-page":"104443","DOI":"10.1016\/j.fitote.2019.104443","article-title":"A review of the pharmacology and toxicology of aucubin","volume":"140","author":"Zeng","year":"2020","journal-title":"Fitoterapia"},{"key":"2025120200422632100_ref9","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12974-020-01863-9","article-title":"Aucubin alleviates oxidative stress and inflammation via Nrf2-mediated signaling activity in experimental traumatic brain injury","volume":"17","author":"Wang","year":"2020","journal-title":"J Neuroinflammation"},{"key":"2025120200422632100_ref10","doi-asserted-by":"crossref","first-page":"109163","DOI":"10.1016\/j.intimp.2022.109163","article-title":"Aucubin promoted neuron functional recovery by suppressing inflammation and neuronal apoptosis in a spinal cord injury model","volume":"111","author":"Xiao","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"2025120200422632100_ref11","doi-asserted-by":"crossref","first-page":"4534411","DOI":"10.1155\/2022\/4534411","article-title":"Aucubin exerts anticancer activity in breast cancer and regulates intestinal microbiota","volume":"2022","author":"Shao","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"key":"2025120200422632100_ref12","doi-asserted-by":"crossref","first-page":"154715","DOI":"10.1016\/j.phymed.2023.154715","article-title":"Aucubin enhances the antitumor activity of cisplatin through the inhibition of PD-L1 expression in hepatocellular carcinoma","volume":"112","author":"Gao","year":"2023","journal-title":"Phytomedicine"},{"key":"2025120200422632100_ref13","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/j.1440-1681.2008.04935.x","article-title":"Antiproliferative activity of aucubin is through cell cycle arrest and apoptosis in human non-small cell lung cancer A549 cells","volume":"35","author":"Hung","year":"2008","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2025120200422632100_ref14","doi-asserted-by":"crossref","first-page":"115440","DOI":"10.1016\/j.bcp.2023.115440","article-title":"Aucubin protects mouse cochlear hair cells from cisplatin-induced ototoxicity via activation of the PI3K\/AKT\/STAT3 pathway","volume":"209","author":"Jiang","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"2025120200422632100_ref15","doi-asserted-by":"crossref","first-page":"153577","DOI":"10.1016\/j.phymed.2021.153577","article-title":"Neuroprotective effects of aucubin on hydrogen peroxide-induced toxicity in human neuroblastoma SH-SY5Y cells via the Nrf2\/HO-1 pathway","volume":"87","author":"Li","year":"2021","journal-title":"Phytomedicine"},{"key":"2025120200422632100_ref16","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/MD.0000000000004766","article-title":"Cancer stem cells: role in tumor growth, recurrence, metastasis, and treatment resistance","volume":"95","author":"Chang","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2025120200422632100_ref17","doi-asserted-by":"crossref","first-page":"e710","DOI":"10.1002\/mco2.710","article-title":"Intricate relationship between cancer stemness, metastasis, and drug resistance","volume":"5","author":"Dakal","year":"2020","journal-title":"MedComm"},{"key":"2025120200422632100_ref18","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41571-019-0293-2","article-title":"Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update","volume":"17","author":"Clara","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"2025120200422632100_ref19","first-page":"a041270","volume-title":"Lung Cancer Stem Cells and their Clinical Implications","author":"Rowbotham","year":"2022"},{"key":"2025120200422632100_ref20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.tips.2023.11.006","article-title":"Biomarkers and targeted therapy for cancer stem cells","volume":"45","author":"Liu","year":"2024","journal-title":"Trends Pharmacol Sci"},{"key":"2025120200422632100_ref21","doi-asserted-by":"crossref","first-page":"115616","DOI":"10.1016\/j.bcp.2023.115616","article-title":"eIF3a sustains non-small cell lung cancer stem cell-like properties by promoting YY1-mediated transcriptional activation of \u03b2-catenin","volume":"213","author":"Zheng","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"2025120200422632100_ref22","doi-asserted-by":"crossref","first-page":"7926483","DOI":"10.1155\/2022\/7926483","article-title":"miR-26a-5p suppresses Wnt\/\u03b2-catenin Signaling pathway by inhibiting DNMT3A-mediated SFRP1 methylation and inhibits cancer stem cell-like properties of NSCLC","volume":"2022","author":"Yu","year":"2022","journal-title":"Dis Markers"},{"key":"2025120200422632100_ref23","doi-asserted-by":"crossref","first-page":"101778","DOI":"10.1016\/j.tranon.2023.101778","article-title":"Histone demethylase KDM6A coordinating with KMT2B regulates self-renewal and chemoresistance of non-small cell lung cancer stem cells","volume":"37","author":"Chen","year":"2023","journal-title":"Transl Oncol"},{"key":"2025120200422632100_ref24","doi-asserted-by":"crossref","first-page":"8096","DOI":"10.1038\/s41598-020-60784-y","article-title":"Allosteric inhibitor of \u03b2-catenin selectively targets oncogenic WNT signaling in colon cancer","volume":"10","author":"Cheltsov","year":"2020","journal-title":"Sci Rep"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/77\/12\/1777\/64236192\/rgaf081.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/77\/12\/1777\/64236192\/rgaf081.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T05:42:34Z","timestamp":1764654154000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/77\/12\/1777\/8250596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":24,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,9,10]]},"published-print":{"date-parts":[[2025,11,28]]}},"URL":"https:\/\/doi.org\/10.1093\/jpp\/rgaf081","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"value":"0022-3573","type":"print"},{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,9,10]]}}}